- Home
- TVTX vs MBIN Comparison
TVTX vs MBIN Comparison
Compare TVTX & MBIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVTX
- MBIN
- Stock Information
- Founded
- TVTX 2008
- MBIN 1990
- Country
- TVTX United States
- MBIN United States
- Employees
- TVTX N/A
- MBIN N/A
- Industry
- TVTX Biotechnology: Pharmaceutical Preparations
- MBIN Major Banks
- Sector
- TVTX Health Care
- MBIN Finance
- Exchange
- TVTX Nasdaq
- MBIN Nasdaq
- Market Cap
- TVTX 1.4B
- MBIN 1.6B
- IPO Year
- TVTX N/A
- MBIN 2017
- Fundamental
- Price
- TVTX $15.63
- MBIN $29.18
- Analyst Decision
- TVTX Strong Buy
- MBIN Buy
- Analyst Count
- TVTX 16
- MBIN 3
- Target Price
- TVTX $33.33
- MBIN $38.33
- AVG Volume (30 Days)
- TVTX 1.2M
- MBIN 202.3K
- Earning Date
- TVTX 08-06-2025
- MBIN 07-28-2025
- Dividend Yield
- TVTX N/A
- MBIN 1.37%
- EPS Growth
- TVTX N/A
- MBIN N/A
- EPS
- TVTX N/A
- MBIN 4.55
- Revenue
- TVTX $273,533,000.00
- MBIN $598,079,000.00
- Revenue This Year
- TVTX $71.61
- MBIN $1.16
- Revenue Next Year
- TVTX $43.45
- MBIN $9.35
- P/E Ratio
- TVTX N/A
- MBIN $6.42
- Revenue Growth
- TVTX 75.65
- MBIN N/A
- 52 Week Low
- TVTX $7.93
- MBIN $27.25
- 52 Week High
- TVTX $25.29
- MBIN $47.94
- Technical
- Relative Strength Index (RSI)
- TVTX 49.00
- MBIN 29.85
- Support Level
- TVTX $15.28
- MBIN $34.07
- Resistance Level
- TVTX $15.97
- MBIN $35.16
- Average True Range (ATR)
- TVTX 0.62
- MBIN 1.23
- MACD
- TVTX -0.06
- MBIN -0.75
- Stochastic Oscillator
- TVTX 28.78
- MBIN 6.01
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.
About MBIN Merchants Bancorp
Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and the Banking segment, which generates maximum revenue, and provides various financial products and services to consumers and businesses.